MiNA Therapeutics Denmark ApS: Financial statements 2023
CVR: 43329545
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MiNA Therapeutics Denmark ApS (CVR 43329545) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,343,378 and a net result of DKK 6,623,979. Equity in the 2023 report amounted to DKK 911,005. The solvency ratio was 42.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 11,343,378
- Profit/Loss
- DKK 6,623,979
- Equity
- DKK 911,005
- Total Assets
- DKK 2,142,066
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 15, 2023, Christopher Barry Wood has left the board of directors of MiNA Therapeutics Denmark ApS.
As of December 15, 2023, Robert Ian Lechler is registered as chairman of MiNA Therapeutics Denmark ApS.
As of December 15, 2023, Nagy Adly Habib has stepped down as chairman of MiNA Therapeutics Denmark ApS.
As of December 14, 2023, Robert Ian Lechler has left the board of directors of MiNA Therapeutics Denmark ApS.
MiNA Therapeutics Denmark ApS has published its interim report for the period June 15, 2022 to December 31, 2022.
As of June 13, 2023, Boreco Statsautoriseret Revisionspartnerselskab has been appointed auditor of MiNA Therapeutics Denmark ApS.
As of June 13, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of MiNA Therapeutics Denmark ApS.
About MiNA Therapeutics Denmark ApS
MiNA Therapeutics Denmark ApS was a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company has been dissolved on 28 May 2026. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 2 employees (2025). In 2024, the company reported a gross profit of DKK 4,727,426 and a net result of DKK 372,506 compared with DKK 6,623,979 the year before. Equity in the 2024 report amounted to DKK 1,283,511.